Modelling Anxiety in Humans for Drug Development

Research output: Contribution to journalReview articleContributed

Contributors

Abstract

Animal behavioural profiles are commonly employed to investigate new therapeutic agents to treat anxiety disorders as well as to investigate the mechanism of action of anxiolytic drugs. However, many clinically important symptoms of anxiety can not be modelled directly in animals. Human models of anxiety should bridge between animal models and anxiety disorders. Experimental anxiety states in humans can be induced by either pharmacological means such as CO2 inhalation or psychological means such as aversive conditioning of skin conductance responses to tones. Investigation of these models may contribute to a better understanding of anxiety disorders, both from a biological and behavioural point of view. In a comprehensive review existing models of human experimental anxiety states are summarized and validity is discussed. © 2007 Bentham Science Publishers Ltd.

Details

Original languageEnglish
Pages (from-to)65-72
Number of pages8
JournalCurrent Neuropharmacology
Volume5
Issue number1
Publication statusPublished - 2007
Peer-reviewedNo

External IDs

Scopus 33947622503
researchoutputwizard legacy.publication#19503

Keywords